News Gedeon Richter LUXEMBOURG S.E.

Stocks

CHWGR

US3684672054

Pharmaceuticals

End-of-day quote LUXEMBOURG S.E. Other stock markets 2026-06-19			5-day change	1st Jan Change
38.40 ^USD	0.00%		-1.03%	+27.15%

06-16	AI in Hungary could unlock productivity gains of EUR15 billion, McKinsey says	RE
06-10	Gedeon Richter Plc. and Hetero Labs Ltd. Announce Global Collaboration Agreement for Joint Development, Registration, and Commercialization of Semaglutide Injection	CI

All News

Mentions Relevance

06-10	Gedeon Richter : Richter and Hetero Announce Global Cooperation for the Development and Commercialization of Semaglutide Injection (Generic of Ozempic®)	PU
06-10	Gedeon Richter Plc. and Hetero Labs Ltd. Announce Global Collaboration Agreement for Joint Development, Registration, and Commercialization of Semaglutide Injection	CI
06-02	For final dividend	FA
05-29	Gedeon Richter PLC Approves Dividend for the Financial Year 2025	CI
05-27	Hungary's Richter and Acrux agree to license transdermal estradiol spray for Australia	RE
05-27	Gedeon Richter : Richter and Acrux agree to license Lenzetto® for Australia	PU
05-15	Gedeon Richter PLC, Q1 2026 Earnings Call, May 12, 2026
05-14	Gedeon Richter : Transactions with Treasury Shares	PU
05-12	Gedeon Richter PLC Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-12	Gedeon Richter : Extraordinary Information	PU
05-12	Hungary's Richter says 2026 guidance fully reiterated high-single-digit growth in revenues and clean EBIT (at constant exchange rates)	RE
05-12	Gedeon Richter : Interim management statement	PU
05-12	Gedeon Richter : RichterIRpresentation May 2026	PU
05-12	Gedeon Richter : PresentationQ12026	PU
05-12	Gedeon Richter : Richter publishes Q1 2026 results	PU
05-12	Gedeon Richter : Earnings presentation Q1 2026 (PresentationQ12026)	PU
05-12	Gedeon Richter : Investor presentation Q1 2026 (RichterIRpresentation May 2026)	PU
05-11	Gedeon Richter Seeks Acquisitions	CI
04-29	Gedeon Richter : Corporate Governance Report from 2025	PU
04-29	Gedeon Richter : AGM Resolutions	PU
04-29	Gedeon Richter : Remuneration Report	PU
04-29	Gedeon Richter : CG Declaration	PU
04-29	Gedeon Richter : GM - Resolutions	PU
04-29	Gedeon Richter : Update on Phase II study of ABBV-932 (RGH-932) for the treatment of bipolar depression	PU
04-29	Gedeon Richter Provides Update On Phase II Clinical Trial Of ABBV-932 (RGH-932) For Bipolar Depression	CI